HER2/neu By FISH

The HER2/neu Gene Amplification by Fluorescence In Situ Hybridization (FISH) test is a molecular diagnostic assay used to assess the amplification of the HER2/neu gene in breast cancer tissue samples. This test plays a crucial role in determining the HER2/neu status, which is important for guiding treatment decisions and predicting patient outcomes.HER2/neu is a gene that codes for a protein receptor found on the surface of cells. Amplification of this gene is associated with an aggressive form of breast cancer and can influence treatment choices.During the HER2/neu Gene Amplification by FISH test, a thin section of breast cancer tissue is prepared on a glass slide. Fluorescently labeled DNA probes are then applied to the tissue sample to target and bind to the HER2/neu gene region. The results are visualized under a fluorescent microscope, and the degree of gene amplification is quantified.The results of this test provide important information about the HER2/neu gene status in the breast cancer tissue. Healthcare providers use this information to determine appropriate treatment options, such as targeted therapies that specifically address the HER2/neu amplification.Scheduling the HER2/neu Gene Amplification by FISH test through our online platform offers a convenient way to access advanced diagnostic assessments. By assessing HER2/neu gene amplification, this test empowers healthcare professionals and individuals to make informed treatment decisions, optimize therapeutic strategies, and provide personalized care for individuals with breast cancer.